GGrantIndex
← Search

Genomics Shared Resource (GSR)

$216,262P30FY2025CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07339085Trial NCT07276438Trial NCT07242365Trial NCT06650163Trial NCT06568016Trial NCT06113016Trial NCT05595499Trial NCT04205838Trial NCT04201873Trial NCT04185311Trial NCT04119024Trial NCT04106362Trial NCT04069923Trial NCT04069910Trial NCT04050215Trial NCT04007029Trial NCT03996850Trial NCT03970252Trial NCT03953157Trial NCT03904251Trial NCT03902951Trial NCT03892720Trial NCT03830918Trial NCT03825796Trial NCT03745690Trial NCT03732950Trial NCT03732352Trial NCT03672773Trial NCT03623854Trial NCT03618134Trial NCT03603223Trial NCT03601455Trial NCT03596710Trial NCT03582774Trial NCT03582475Trial NCT03541850Trial NCT03515577Trial NCT03506802Trial NCT03425461Trial NCT03411070Trial NCT03368547Trial NCT03319342Trial NCT03240861Trial NCT03202472Trial NCT03128619Trial NCT03025139Trial NCT03014804Trial NCT02940262Trial NCT02928510Trial NCT02925351Trial NCT02919332Trial NCT02902757Trial NCT02888301Trial NCT02881242Trial NCT02880020Trial NCT02879994Trial NCT02830165Trial NCT02816879Trial NCT02775292Trial NCT02756130Trial NCT02701153Trial NCT02688348Trial NCT02683200Trial NCT02672033Trial NCT02597894Trial NCT02575027Trial NCT02451865Trial NCT02336763Trial NCT02310594Trial NCT02296229Trial NCT02280161Trial NCT02263898Trial NCT02176902Trial NCT02070406Trial NCT02049593Trial NCT02048020Trial NCT02015559Trial NCT01912820Trial NCT01013285Trial NCT01005472Trial NCT00999557Trial NCT00998010Trial NCT00985192Trial NCT00955591Trial NCT00882765Trial NCT00880542Trial NCT00769470Trial NCT00706615Trial NCT00685516Trial NCT00616642Trial NCT00612066Trial NCT00601289Trial NCT00601094Trial NCT00521209Trial NCT00509431Trial NCT00471887Trial NCT00450567Trial NCT00444223Trial NCT00352001Trial NCT00349167

Abstract

GENOMICS SHARED RESOURCE (GSR) ABSTRACT The objective of the UCLA Jonsson Comprehensive Cancer Center (JCCC) Genomics Shared Resource (GSR) is to enable and enhance members’ cancer research. This objective is being achieved through mechanisms that group into: (1) Developing state-of-the-art next generation sequencing (NGS) technologies, services, and solutions; (2) Fostering interdisciplinary collaborations and interactions; (3) Providing ready access to technologies, services, and scientific consultations; and (4) Furthering productivity to maximize the scientific impact of JCCC investigator research. GSR management within the JCCC is led by Associate Director of Shared Resources Zoran Galic, PhD (TII), and a four-member GSR Faculty Advisory Committee (FAC), in collaboration with Elaine Reed, PhD, Endowed Chair in Diagnostic Medicine, Professor of Pathology and Laboratory Medicine and Director of the UCLA Immunogenetics Center. Under the leadership of GSR Director Xinmin Li, PhD (ERGR), and Co-Director Hyun-Ju Lim, PhD, GSR has a highly trained team of 18 genomics and bioinformatics staff, including nine PhD scientists. Housed within GSR are cutting-edge genomics technologies including a Novaseq X plus sequencer, DNBseq T7 sequencer, GridION long sequencer, 10X Chromium IX and BD Rhapsody single cell systems, a 10X Visium CytAssist, a 10X Xenium Analyzer, a GeoMx Digital Spatial Profiler, a CosMx Spatial Molecular Imager, a 10X Genomics Chromium Connect, a Beckman Coulter Biomek i7, and a Life Tech EVOS M7000 microscope. Empowered by these recent technological innovations and capabilities, GSR provides >70 different genomics menu services, including bulk, single cell, and spatial multi-omics analyses and data management that are timely and cost-effective. GSR services are prioritized for JCCC members. GSR also offers alternative platforms for major technologies tailored to meet specific scientific requirements. This variety of capabilities enable JCCC investigators to tackle a wide range of complex and multifaceted questions. From 2019 – 2023, GSR served 111 different JCCC investigators from all six JCCC Research Programs. In addition to providing services, GSR supports JCCC investigator labs with education, consultation, expertise, and innovation. Since 2019, GSR has offered 31 lectures, seminars, and workshops with approximate attendance by JCCC members ~650 times at these events. Li has written >130 grant support letters, with approximately 18% funded, and has provided expert revisions for numerous manuscripts and grant applications. This multidimensional support resulted in impressive scientific and financial impact, with GSR support contributing to 226 publications with 55% appearing in high-impact (IF >10) journals, newly awarded extramural grants totaling $193M, and 21 patent applications from 2019 – 2023. GSR has consistently shown and will continuously make impactful contributions to JCCC cancer research, which prioritizes the needs of its Los Angeles County catchment area residents.

View original record on NIH RePORTER →